BIOLASE, INC Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Biolase, Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Biolase, Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $5.65M, a 33.7% decline year-over-year.
  • Biolase, Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $17.4M, a 279% increase from 2022.
  • Biolase, Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $4.6M, a 84.6% decline from 2021.
  • Biolase, Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $30M, a 23% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $17.4M +$12.8M +279% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $4.6M -$25.4M -84.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $30M +$5.61M +23% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-21
2020 $24.3M +$13.6M +127% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-28
2019 $10.7M -$514K -4.58% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-17
2018 $11.2M -$10.4M -48% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-31
2017 $21.6M +$12.3M +131% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-30
2016 $9.35M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-08
2013 $8.85M +$7.29M +467% Jan 1, 2013 Dec 31, 2013 10-K 2014-03-17
2012 $1.56M -$13.8M -89.9% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-17
2011 $15.4M +$12.6M +447% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-17
2010 $2.81M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.